Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RenovoRx (RNXT)

RenovoRx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNXT
DateTimeSourceHeadlineSymbolCompany
08/01/202513:00Business WireRenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025NASDAQ:RNXTRenovoRx Inc
30/12/202413:00Business WireRenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy PlatformNASDAQ:RNXTRenovoRx Inc
11/12/202413:00GlobeNewswire Inc.RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic CancerNASDAQ:RNXTRenovoRx Inc
10/12/202413:00GlobeNewswire Inc.RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ETNASDAQ:RNXTRenovoRx Inc
05/12/202413:00GlobeNewswire Inc.RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery SystemNASDAQ:RNXTRenovoRx Inc
20/11/202413:45GlobeNewswire Inc.Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
14/11/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
14/11/202413:00GlobeNewswire Inc.RenovoRx Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
13/11/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
02/10/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
02/10/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
25/09/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
25/09/202412:30GlobeNewswire Inc.RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology PhysiciansNASDAQ:RNXTRenovoRx Inc
19/09/202412:30GlobeNewswire Inc.RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic CancerNASDAQ:RNXTRenovoRx Inc
27/08/202412:30GlobeNewswire Inc.RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New YorkNASDAQ:RNXTRenovoRx Inc
16/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
14/08/202412:30GlobeNewswire Inc.RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
13/08/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
31/07/202412:30GlobeNewswire Inc.RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®NASDAQ:RNXTRenovoRx Inc
08/07/202412:30GlobeNewswire Inc.RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®NASDAQ:RNXTRenovoRx Inc
26/06/202412:30GlobeNewswire Inc.University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical TrialNASDAQ:RNXTRenovoRx Inc
10/06/202412:30GlobeNewswire Inc.RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and PartnershipsNASDAQ:RNXTRenovoRx Inc
07/06/202420:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
30/05/202412:30Business WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
21/05/202413:00Business WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
14/05/202413:00Business WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
13/05/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
13/05/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
10/05/202421:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/05/202420:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
 Showing the most relevant articles for your search:NASDAQ:RNXT